Insider · CIK 0001662556

Yi Qingqing

Reports to the SEC for 1 company · GEORGETOWN, GRAND CAYMAN

sec.gov

Transactions

Companies

Filings

CIK

0001662556

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−235 sh	$279.13	−$65.6K	0
2025-06-10	ONCBeOne Medicines Ltd.J Other	Director	JOther	−29.6K sh	—	—	27,326
2025-05-21	ONCBeOne Medicines Ltd.A Award	Director	AAward	+11K sh	—	—	56,940
2025-05-21	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,750
2024-06-05	ONCBeOne Medicines Ltd.A Award	Director	AAward	+16.3K sh	—	—	45,955
2024-06-05	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+34.2K sh	—	—	34,151
2023-06-15	ONCBeOne Medicines Ltd.A Award	Director	AAward	+12.9K sh	—	—	29,614
2023-06-15	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	26,975
2022-08-22	ONCBeOne Medicines Ltd.J Other	Director	JOther	−7,800 sh	—	—	16,692
2022-06-22	ONCBeOne Medicines Ltd.A Award	Director	AAward	+16.7K sh	—	—	24,492
2022-06-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	−34.6K sh	—	—	34,645
2021-06-16	ONCBeOne Medicines Ltd.A Award	Director	AAward	+7,800 sh	—	—	7,800
2021-06-16	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,498
2020-06-17	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	−45.4K sh	—	—	45,383
2019-06-17	ONCBeOne Medicines Ltd.J Other	Director	JOther	−9,282 sh	—	—	0
2019-06-05	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+64.6K sh	—	—	64,610
2018-06-06	ONCBeOne Medicines Ltd.A Award	Director	AAward	+9,290 sh	—	—	9,290
2018-06-06	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+17.4K sh	—	—	17,442
2017-04-19	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+200K sh	—	—	199,992

Recent filings

Accepted (ET)
Jun 34
Yi Qingqing0000919574-26-003800
SEC(opens sec.gov)
Jun 124
Yi Qingqing0000902664-25-002711
SEC(opens sec.gov)
May 234
Yi Qingqing0000902664-25-002529
SEC(opens sec.gov)
Jun 74
Yi Qingqing0000902664-24-004124
SEC(opens sec.gov)
Jun 204
Yi Qingqing0000902664-23-003641
SEC(opens sec.gov)
Aug 244
Yi Qingqing0000902664-22-004101
SEC(opens sec.gov)
Jun 244
Yi Qingqing0000902664-22-003398
SEC(opens sec.gov)
Jun 244
Yi Qingqing0000902664-21-003255
SEC(opens sec.gov)
Jun 194
Yi Qingqing0000902664-20-002459
SEC(opens sec.gov)
Jun 184
Yi Qingqing0000902664-19-002801
SEC(opens sec.gov)
Jun 114
Yi Qingqing0000902664-19-002708
SEC(opens sec.gov)
Jun 84
Yi Qingqing0000902664-18-002540
SEC(opens sec.gov)
Apr 214
BeiGene, Ltd.0000902664-17-002041
SEC(opens sec.gov)

Companies

BeOne Medicines Ltd.DirectorONC

Address

OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK

GEORGETOWN, GRAND CAYMAN, KY1 1103